These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 26002564)
1. High neuroendocrine component is a factor for poor prognosis in gastrointestinal high-grade malignant mixed adenoneuroendocrine neoplasms. Chen MH; Kuo YJ; Yeh YC; Lin YC; Tzeng CH; Liu CY; Chang PM; Chen MH; Jeng YM; Chao Y J Chin Med Assoc; 2015 Aug; 78(8):454-9. PubMed ID: 26002564 [TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal mixed adenoneuroendocrine carcinoma (MANEC): An immunohistochemistry study of 13 microsatellite stable cases. Gurzu S; Fetyko A; Bara T; Banias L; Butiurca VO; Bara T; Tudorache V; Jung I Pathol Res Pract; 2019 Dec; 215(12):152697. PubMed ID: 31704155 [TBL] [Abstract][Full Text] [Related]
3. Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: report of two cases. Gurzu S; Kadar Z; Bara T; Bara T; Tamasi A; Azamfirei L; Jung I World J Gastroenterol; 2015 Jan; 21(4):1329-33. PubMed ID: 25632209 [TBL] [Abstract][Full Text] [Related]
4. Long-term control with chemoradiation of initially metastatic mixed adenoneuroendocrine carcinoma of the rectum: a case report. Semrau S; Agaimy A; Pavel M; Lubgan D; Schmidt D; Cavallaro A; Golcher H; Grützmann R; Fietkau R J Med Case Rep; 2019 Mar; 13(1):82. PubMed ID: 30902067 [TBL] [Abstract][Full Text] [Related]
5. Oncologic outcome of mixed adenoneuroendocrine carcinoma (MANEC): A single center case series. Dulskas A; Pilvelis A Eur J Surg Oncol; 2020 Jan; 46(1):105-107. PubMed ID: 31444026 [TBL] [Abstract][Full Text] [Related]
6. [Gastrointestinal mixed adenoneuroendocrine carcinomas. An attempt at classification of mixed cancers]. Reu S; Neumann J; Kirchner T Pathologe; 2012 Feb; 33(1):31-8. PubMed ID: 22293787 [TBL] [Abstract][Full Text] [Related]
7. Mixed adenoneuroendocrine carcinoma (MANEC) of the lower gastrointestinal tract: A systematic review with Bayesian hierarchical survival analysis. Grossi U; Bonis A; Carrington EV; Mazzobel E; Santoro GA; Cattaneo L; Centonze G; Gallo G; Kazemi Nava A; Romano M; Di Tanna GL; Zanus G Eur J Surg Oncol; 2021 Nov; 47(11):2893-2899. PubMed ID: 34052038 [TBL] [Abstract][Full Text] [Related]
9. Primary Biliary Mixed Adenoneuroendocrine Carcinoma (MANEC): A Short Review. Acosta AM; Wiley EL Arch Pathol Lab Med; 2016 Oct; 140(10):1157-62. PubMed ID: 27684986 [TBL] [Abstract][Full Text] [Related]
10. Gastric mixed adenoneuroendocrine carcinoma: correlation of histologic characteristics with prognosis. Nie L; Li M; He X; Feng A; Wu H; Fan X Ann Diagn Pathol; 2016 Dec; 25():48-53. PubMed ID: 27806846 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features and lymph node metastatic patterns of gastric mixed adenoneuroendocrine carcinoma. Chen H; Shu M; Chen S; Xue L; Lin Y Histol Histopathol; 2019 Apr; 34(4):373-379. PubMed ID: 30238962 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasm. Zhang P; Li Z; Li J; Li J; Zhang X; Lu Z; Sun Y; Li Y; Zhou J; Wang X; Peng Z; Shen L; Lu M Cancer Med; 2021 Jul; 10(14):4855-4863. PubMed ID: 34109756 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma. Lim SM; Kim H; Kang B; Kim HS; Rha SY; Noh SH; Hyung WJ; Cheong JH; Kim HI; Chung HC; Yun M; Cho A; Jung M Ann Nucl Med; 2016 May; 30(4):279-86. PubMed ID: 26837515 [TBL] [Abstract][Full Text] [Related]
14. [Gastric mixed adenoneuroendocrine carcinoma: a clinicopathological analysis of 36 cases]. Gao R; Chen XY; Jin L Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):767-771. PubMed ID: 31594040 [No Abstract] [Full Text] [Related]
15. Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients. Xie JW; Lu J; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Li P; Huang CM BMC Cancer; 2018 Oct; 18(1):1021. PubMed ID: 30348122 [TBL] [Abstract][Full Text] [Related]
16. Mixed adenoneuroendocrine carcinoma of the urethra. Raison N; McGovern U; Hines J; Volanis D BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30902843 [TBL] [Abstract][Full Text] [Related]
17. Cytological features of mixed adenoneuroendocrine carcinoma of the ampulla: two case reports with review of literature. Zhang L; DeMay RM Diagn Cytopathol; 2014 Dec; 42(12):1075-84. PubMed ID: 24554593 [TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma. Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148 [TBL] [Abstract][Full Text] [Related]
19. Mixed adenoneuroendocrine carcinoma (MANEC) of the ampulla of Vater in a Chinese patient: A case report. Li X; Li D; Sun X; Lv G J Int Med Res; 2020 Aug; 48(8):300060520947918. PubMed ID: 32833541 [TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine liver metastasis in gastric mixed adenoneuroendocrine carcinoma with trilineage cell differentiation: a case report. Zhang W; Xiao W; Ma H; Sun M; Chen H; Zheng S Int J Clin Exp Pathol; 2014; 7(9):6333-8. PubMed ID: 25337287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]